Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2′,2′-difluorodeoxycytidine on human hepatoma HepG2 cells
- 31 March 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (3) , 504-509
- https://doi.org/10.1016/s0168-8278(98)80326-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in JapanHepatology, 1995
- Therapy of Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B*1Hepatology, 1995
- Hepatocellular Carcinoma in CirrhoticsSeminars in Liver Disease, 1993
- Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liverGastroenterology, 1992
- Treatment of small hepatocellular carcinomasThe Lancet, 1992
- A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in JapanCancer, 1991
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- Hepatocellular carcinoma and dietary aflatoxin in Mozambique and TranskeiBritish Journal of Cancer, 1985